Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
< 26 27 26 27 O
1.0 28 31 28 31 B-upper_bound
x 32 33 32 33 I-upper_bound
10 34 36 34 36 I-upper_bound
^ 36 37 36 37 I-upper_bound
9 37 38 37 38 I-upper_bound
/ 38 39 38 39 I-upper_bound
L 39 40 39 40 I-upper_bound

Aspartate 0 9 41 50 B-clinical_variable
aminotransferase 10 26 51 67 I-clinical_variable
( 27 28 68 69 I-clinical_variable
AST 28 31 69 72 I-clinical_variable
) 31 32 72 73 I-clinical_variable
and 33 36 74 77 O
alanine 37 44 78 85 B-clinical_variable
aminotransferase 45 61 86 102 I-clinical_variable
( 62 63 103 104 I-clinical_variable
ALT 63 66 104 107 I-clinical_variable
) 66 67 107 108 I-clinical_variable
at 68 70 109 111 O
screening 71 80 112 121 O
> 81 82 122 123 O
3x 83 85 124 126 B-lower_bound
upper 86 91 127 132 I-lower_bound
limit 92 97 133 138 I-lower_bound
of 98 100 139 141 I-lower_bound
normal 101 107 142 148 I-lower_bound
( 108 109 149 150 I-lower_bound
ULN 109 112 150 153 I-lower_bound
) 112 113 153 154 I-lower_bound

Bilirubin 0 9 155 164 B-clinical_variable
> 10 11 165 166 O
1.5 12 15 167 170 B-lower_bound
mg 16 18 171 173 I-lower_bound
/ 18 19 173 174 I-lower_bound
dL 19 21 174 176 I-lower_bound

Clinically 0 10 177 187 O
significant 11 22 188 199 O
cardiac 23 30 200 207 B-chronic_disease
/ 30 31 207 208 I-chronic_disease
cardiovascular 31 45 208 222 I-chronic_disease
disease 46 53 223 230 I-chronic_disease
, 53 54 230 231 O
or 55 57 232 234 O
pulmonary 58 67 235 244 B-chronic_disease
compromise 68 78 245 255 I-chronic_disease

Cytotoxic 0 9 256 265 B-treatment
chemotherapy 10 22 266 278 I-treatment
, 22 23 278 279 O
radiotherapy 24 36 280 292 B-treatment
, 36 37 292 293 O
or 38 40 294 296 O
immunotherapy 41 54 297 310 B-treatment
within 55 61 311 317 O
4 62 63 318 319 B-upper_bound
weeks 64 69 320 325 I-upper_bound
, 69 70 325 326 O
or 71 73 327 329 O
small 74 79 330 335 O
molecule 80 88 336 344 O
or 89 91 345 347 O
investigational 92 107 348 363 O
agents 108 114 364 370 O
within 115 121 371 377 O
6 122 123 378 379 B-upper_bound
elimination 124 135 380 391 O
half 136 140 392 396 O
- 140 141 396 397 O
lives 141 146 397 402 O
of 147 149 403 405 O
the 150 153 406 409 O
first 154 159 410 415 O
dose 160 164 416 420 O
of 165 167 421 423 O
XmAb13676 168 177 424 433 B-treatment

Diagnosis 0 9 434 443 O
of 10 12 444 446 O
either 13 19 447 453 O
Non 20 23 454 457 B-cancer
- 23 24 457 458 I-cancer
CLL 24 27 458 461 I-cancer
B 28 29 462 463 I-cancer
cell 30 34 464 468 I-cancer
malignancy 35 45 469 479 I-cancer
or 46 48 480 482 O
CLL 49 52 483 486 O
/ 52 53 486 487 O
SLL 53 56 487 490 B-cancer

Estimated 0 9 491 500 O
creatinine 10 20 501 511 B-clinical_variable
clearance 21 30 512 521 I-clinical_variable
< 31 32 522 523 O
50 33 35 524 526 B-upper_bound
mL 36 38 527 529 I-upper_bound
/ 38 39 529 530 I-upper_bound
min 39 42 530 533 I-upper_bound

Evidence 0 8 534 542 O
of 9 11 543 545 O
any 12 15 546 549 O
serious 16 23 550 557 O
bacterial 24 33 558 567 B-chronic_disease
, 33 34 567 568 O
viral 35 40 569 574 B-chronic_disease
, 40 41 574 575 O
parasitic 42 51 576 585 B-chronic_disease
or 52 54 586 588 I-chronic_disease
systemic 55 63 589 597 I-chronic_disease
fungal 64 70 598 604 I-chronic_disease
infections 71 81 605 615 I-chronic_disease
within 82 88 616 622 O
the 89 92 623 626 O
30 93 95 627 629 B-upper_bound
days 96 100 630 634 I-upper_bound
prior 101 106 635 640 I-upper_bound
to 107 109 641 643 O
study 110 115 644 649 O
entry 116 121 650 655 O

Failure 0 7 656 663 O
to 8 10 664 666 O
recover 11 18 667 674 O
from 19 23 675 679 O
Grade 24 29 680 685 B-lower_bound
3 30 31 686 687 I-lower_bound
or 32 34 688 690 O
4 35 36 691 692 B-upper_bound
toxicity 37 45 693 701 O
from 46 50 702 706 O
previous 51 59 707 715 B-treatment
treatment 60 69 716 725 I-treatment

Fertile 0 7 726 733 O
patients 8 16 734 742 O
must 17 21 743 747 O
agree 22 27 748 753 B-contraception_consent
to 28 30 754 756 I-contraception_consent
use 31 34 757 760 I-contraception_consent
effective 35 44 761 770 I-contraception_consent
contraception 45 58 771 784 I-contraception_consent
during 59 65 785 791 O
and 66 69 792 795 O
for 70 73 796 799 O
4 74 75 800 801 B-upper_bound
weeks 76 81 802 807 I-upper_bound
after 82 87 808 813 O
completion 88 98 814 824 O
of 99 101 825 827 O
study 102 107 828 833 O

History 0 7 834 841 O
or 8 10 842 844 O
evidence 11 19 845 853 O
of 20 22 854 856 O
a 23 24 857 858 O
clinically 25 35 859 869 O
unstable 36 44 870 878 O
/ 44 45 878 879 O
uncontrollable 45 59 879 893 O
disorder 60 68 894 902 O
, 68 69 902 903 O
condition 70 79 904 913 O
or 80 82 914 916 O
disease 83 90 917 924 O
other 91 96 925 930 O
than 97 101 931 935 O
primary 102 109 936 943 O
malignancy 110 120 944 954 B-cancer
, 120 121 954 955 O
that 122 126 956 960 O
in 127 129 961 963 O
the 130 133 964 967 O
opinion 134 141 968 975 O
of 142 144 976 978 O
the 145 148 979 982 O
Investigator 149 161 983 995 O
would 162 167 996 1001 O
pose 168 172 1002 1006 O
a 173 174 1007 1008 O
risk 175 179 1009 1013 O
to 180 182 1014 1016 O
the 183 186 1017 1020 O
patient 187 194 1021 1028 O
safety 195 201 1029 1035 O
or 202 204 1036 1038 O
interfere 205 214 1039 1048 O
with 215 219 1049 1053 O
the 220 223 1054 1057 O
study 224 229 1058 1063 O
evaluation 230 240 1064 1074 O
, 240 241 1074 1075 O
procedures 242 252 1076 1086 O
or 253 255 1087 1089 O
completion 256 266 1090 1100 O

Known 0 5 1101 1106 O
intolerance 6 17 1107 1118 O
to 18 20 1119 1121 O
CD20 21 25 1122 1126 B-allergy_name
monoclonal 26 36 1127 1137 I-allergy_name
antibody 37 45 1138 1146 I-allergy_name
therapy 46 53 1147 1154 I-allergy_name

Last 0 4 1155 1159 O
dose 5 9 1160 1164 O
of 10 12 1165 1167 O
anti 13 17 1168 1172 B-treatment
- 17 18 1172 1173 I-treatment
CD20 18 22 1173 1177 I-treatment
antibody 23 31 1178 1186 I-treatment
therapy 32 39 1187 1194 I-treatment
must 40 44 1195 1199 O
have 45 49 1200 1204 O
been 50 54 1205 1209 O
> 55 56 1210 1211 O
4 56 57 1211 1212 B-lower_bound
weeks 58 63 1213 1218 I-lower_bound
before 64 70 1219 1225 O
the 71 74 1226 1229 O
first 75 80 1230 1235 O
dose 81 85 1236 1240 O
of 86 88 1241 1243 O
XmAb13676 89 98 1244 1253 B-treatment

Multiple 0 8 1254 1262 B-cancer
myeloma 9 16 1263 1270 I-cancer
/ 16 17 1270 1271 O
plasma 17 23 1271 1277 B-cancer
cell 24 28 1278 1282 I-cancer
leukemia 29 37 1283 1291 I-cancer
or 38 40 1292 1294 O
B 41 42 1295 1296 B-cancer
cell 43 47 1297 1301 I-cancer
acute 48 53 1302 1307 I-cancer
lymphoblastic 54 67 1308 1321 I-cancer
leukemia 68 76 1322 1330 I-cancer

Not 0 3 1331 1334 O
a 4 5 1335 1336 O
candidate 6 15 1337 1346 O
for 16 19 1347 1350 O
or 20 22 1351 1353 O
refusing 23 31 1354 1362 O
treatment 32 41 1363 1372 B-treatment
with 42 46 1373 1377 I-treatment
hematopoietic 47 60 1378 1391 I-treatment
stem 61 65 1392 1396 I-treatment
cell 66 70 1397 1401 I-treatment
transplantation 71 86 1402 1417 I-treatment

Platelet 0 8 1418 1426 B-clinical_variable
count 9 14 1427 1432 I-clinical_variable
< 15 16 1433 1434 O
50 17 19 1435 1437 B-upper_bound
x 20 21 1438 1439 I-upper_bound
10 22 24 1440 1442 I-upper_bound
^ 24 25 1442 1443 I-upper_bound
9 25 26 1443 1444 I-upper_bound
/ 26 27 1444 1445 I-upper_bound
L 27 28 1445 1446 I-upper_bound

Seizure 0 7 1447 1454 B-chronic_disease
disorder 8 16 1455 1463 I-chronic_disease

planning 0 8 1464 1472 B-pregnancy
to 9 11 1473 1475 I-pregnancy
become 12 18 1476 1482 I-pregnancy
pregnant 19 27 1483 1491 I-pregnancy
while 28 33 1492 1497 O
enrolled 34 42 1498 1506 O
in 43 45 1507 1509 O
the 46 49 1510 1513 O
study 50 55 1514 1519 O
, 55 56 1519 1520 O
up 57 59 1521 1523 O
to 60 62 1524 1526 O
the 63 66 1527 1530 O
End 67 70 1531 1534 O
of 71 73 1535 1537 O
Study 74 79 1538 1543 O
visit 80 85 1544 1549 O

